Summary
82 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 23% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $214.6M in the last fiscal year, 4.9% of its market value.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 12.4 USD for 1 USD of yearly profit. Over the last five years it was 9.7 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 24% a year over 5 years. Over the last 3 years it grew by 22% a year. Earnings per share grew by 23% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 26 USD
- Research and development 2.2 USD
- Sales and administration 44 USD
- Taxes and other 16 USD
- Net profit 12 USD
Net profit, industry median (Financial - Credit Services) 16 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $247.6 is 39% above today's price. 70% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- UNITED STATES 97%
- Non-US 2.5%
UNITED STATES brings in 97% of revenue.
Segments in detail